SCHEMBL29789952

SCHEMBL29789952

CC1(C)C=Cc2ccc(-c3ccccn3)cc2N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 1/20 0.36
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PI4KA P42356 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ PI4KB Q9UBF8 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ CCR1 P32246 1/20 0.35
▸ CCR5 P51681 1/20 0.35
▸ CCR8 P51685 1/20 0.35
▸ METAP1 P53582 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23123380 1.00 PDK2 (0.36) PDK2CYP1A2CYP2D6CYP19A1CYP2C9
SCHEMBL15630460 0.77 MAPT (0.50) PDK2CYP1A2CYP2D6CYP19A1CYP2C9
SCHEMBL21846250 0.77 PDK2 (0.40) PDK2CYP1A2CYP2D6CYP19A1CYP2C9
SCHEMBL29789803 0.73 CCNC (0.34) PDK2PIK3CDPIK3CAPIK3CG
SCHEMBL23123529 0.70 PGR (0.37) CYP1A2KDM4ELMNAPOLBCCR1
SCHEMBL29790013 0.70 PGR (0.37) CYP1A2KDM4ELMNAPOLBCCR1
SCHEMBL29789697 0.69 MAPT (0.50) PDK2KDM4ECYP3A4
SCHEMBL18289150 0.69 PDK2 (0.44) PDK2CYP1A2CYP2D6CYP19A1CYP2C9
SCHEMBL23123980 0.69 AR (0.43) PDK2CYP1A2CYP2D6CYP19A1CYP2C9
SCHEMBL12721336 0.67 PDK2 (0.48) PDK2CYP1A2CYP2D6CYP19A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114901652-A Substituted saturated and unsaturated N-heterocyclic carboxamides and related compounds for the treatment of medical disorders 比亚尔R&D投资股份公司 2022-08-12 — — CN disclosed
EP-4031540-A1 SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 — — EP disclosed
Send feedback